Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Dietmar M. Wagenknecht is active.

Publication


Featured researches published by Dietmar M. Wagenknecht.


Pharmaceutical Research | 1988

An accurate prediction of the ph change due to degradation correction for a produced secondary buffering system

Leonard S. Rosenberg; Cheryl K. Hostetler; Dietmar M. Wagenknecht; Diane A. Aunet

Esmolol hydrochloride degrades in aqueous solutions by the hydrolysis of a labile aliphatic carboxy-ester group. The products are methanol and ASL-8123. The resulting aliphatic carboxylic acid moiety (ASL-8123) has a pK of 4.80, which is within 1 pH unit of the pH of the formulation. ASL-8123 therefore acts as a “secondary buffer” and minimizes the change in pH due to degradation. Equations are presented to calculate the change in the pH when the primary degradation product acts as a secondary buffer. This information can be used in the development of a parenteral product to predict, a priori, the concentration of buffer necessary for optimal pH maintenance. This knowledge can reduce the number of formulation screens required to determine the necessary buffer capacity for optimal drug stability.


Archive | 1989

Stable pharmaceutical composition

Leonard S. Rosenberg; Cheryl K. Black; Earl R. Speicher; Dietmar M. Wagenknecht


Archive | 1985

Pharmaceutical composition and method of treatment or prophylaxis of cardiac disorders

Agustin Escobar; Dietmar M. Wagenknecht; Ahmad Waseem Malick


Archive | 1984

Stable pharmaceutical compositions of short-acting β-adrenergic receptor blocking agents

Agustin Escobar; Dietmar M. Wagenknecht; Abu S. Alam


Archive | 1983

Arenteral infusion of nitroglycerin solutions

Dietmar M. Wagenknecht; Anton H. Amann; Daphne R. Gallagher


Archive | 1989

Stable pharmaceutical composition containing esmolol

Earl R. Speicher; Cheryl K. Black; Dietmar M. Wagenknecht; Leonard S. Rosenberg


Archive | 1989

Stabile pharmazeutische zusammensetzung. The stable pharmaceutical composition.

Leonard S. Rosenberg; Cheryl K. Black; Earl R. Speicher; Dietmar M. Wagenknecht


Archive | 1989

Stabile pharmazeutische zusammensetzung

Leonard S. Rosenberg; Cheryl K. Black; Earl R. Speicher; Dietmar M. Wagenknecht


Archive | 1989

Composition pharmaceutique stable

Leonard S. Rosenberg; Cheryl K. Black; Earl R. Speicher; Dietmar M. Wagenknecht


Archive | 1985

Pharmaceutical composition suitable for treatment or prophylaxis of cardiac disorders

Agustin Escobar; Dietmar M. Wagenknecht; Ahmad Waseem Malick

Collaboration


Dive into the Dietmar M. Wagenknecht's collaboration.

Researchain Logo
Decentralizing Knowledge